Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riitta Lassila

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Journal of Cardiovascular Pharmacology|June 16, 2021
Safety and Functional Pharmacokinetic Profile of APAC, a Novel Intravascular Antiplatelet and AnticoagulantSimon Craige, Annukka Jouppila, Bob Humphries, et al.
World Journal of Orthopedics|November 3, 2017
Total joint replacement in inhibitor-positive haemophilia: Long-term outcome analysis in fifteen patientsHeidi Danielson, Riitta Lassila, Pekka Ylinen, et al.
BMJ Open|November 8, 2014
The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort studyRiitta Lassila, Antti Jula, Janne Pitkäniemi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 17, 2025
Advances in Von Willebrand DiseaseRiitta Lassila, Ferdows Atiq, Caterina Casari, et al.
Annals of Medicine|December 3, 2024
Venous thromboembolism treatment failure during use of factor Xa inhibitors-association with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertensionMatti Kaksonen, Piia Simonen, Riitta Lassila, et al.
Diabetes & Vascular Disease Research|June 21, 2024
A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbiditiesLasse Myllylahti, Leo Niskanen, Riitta Lassila, et al.
Neurosurgery|July 1, 2005
D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activitySorella Ilveskero, Seppo Juvela, Jari Siironen, et al.
Thrombosis Research|February 26, 2010
Comparison of monitoring methods for lepirudin: impact of warfarin and lupus anticoagulantBirgitta Salmela, Lotta Joutsi-Korhonen, Ellen Saarela, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysisBirgitta Salmela, Lotta Joutsi-Korhonen, Elina Armstrong, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
New insights into von Willebrand disease and platelet functionTímea Szántó, Lotta Joutsi-Korhonen, Hans Deckmyn, et al.
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Journal of Cardiovascular Pharmacology|June 16, 2021
Safety and Functional Pharmacokinetic Profile of APAC, a Novel Intravascular Antiplatelet and AnticoagulantSimon Craige, Annukka Jouppila, Bob Humphries, et al.
World Journal of Orthopedics|November 3, 2017
Total joint replacement in inhibitor-positive haemophilia: Long-term outcome analysis in fifteen patientsHeidi Danielson, Riitta Lassila, Pekka Ylinen, et al.
BMJ Open|November 8, 2014
The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort studyRiitta Lassila, Antti Jula, Janne Pitkäniemi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 17, 2025
Advances in Von Willebrand DiseaseRiitta Lassila, Ferdows Atiq, Caterina Casari, et al.
Annals of Medicine|December 3, 2024
Venous thromboembolism treatment failure during use of factor Xa inhibitors-association with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertensionMatti Kaksonen, Piia Simonen, Riitta Lassila, et al.
Diabetes & Vascular Disease Research|June 21, 2024
A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbiditiesLasse Myllylahti, Leo Niskanen, Riitta Lassila, et al.
Neurosurgery|July 1, 2005
D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activitySorella Ilveskero, Seppo Juvela, Jari Siironen, et al.
Thrombosis Research|February 26, 2010
Comparison of monitoring methods for lepirudin: impact of warfarin and lupus anticoagulantBirgitta Salmela, Lotta Joutsi-Korhonen, Ellen Saarela, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysisBirgitta Salmela, Lotta Joutsi-Korhonen, Elina Armstrong, et al.
Seminars in Thrombosis and Hemostasis|February 9, 2012
New insights into von Willebrand disease and platelet functionTímea Szántó, Lotta Joutsi-Korhonen, Hans Deckmyn, et al.
Pageof 17